Background {#Sec1}
==========

Chickens are economically significant animals. Skeletal muscle constitutes the largest proportion and most valuable component of meat mass; its development is closely associated with the amount of meat production and its quality. Together with muscular histological traits, such as the type, diameter, density and size of muscle fibers, the deposition of intramuscular fat (IMF) can dramatically promote tenderness of meat and plays an important role in flavor of meat \[[@CR1]--[@CR3]\].

The development of skeletal muscle depends on myogenesis and, to some extent, also on adipogenesis. The muscle mass and IMF content are both determined by cell numbers and unit cell size. Hyperplasia refers to the increasing in cell number or muscle fiber number which occurs mainly in embryonic periods as the numbers of adipocytes and muscle fibers are fixed by the day of hatching \[[@CR4], [@CR5]\]. Velleman et al. (2007) observed that breast muscle organizational differences among breeds and between sexes begin to occur between embryonic 20 days (ED 20) and ED 25 in turkeys. Thus, embryonic muscle development has a dramatic impact on the postnatal accretion of muscle mass and its content of IMF \[[@CR6]\]. Chartrin et al. (2007) investigated the effects of age (from D 1 to D 98) on IMF of mule ducks and showed that total lipid content in the breast muscle was high at D 1 and indicated that embryonic IMF was necessary for growth and energy requirements at this early stage \[[@CR7]\]. Our previous study as reported by Liu et al. (2016) also showed that chicken IMF content was highest at D 1 and the protein expression profile at D 1 differed greatly from other post-hatching ages \[[@CR8]\]. The previous molecular studies of muscle development and IMF deposition in poultry have been mainly focused on post-hatchling stages, except for Ouyang's recent report on the proteomic analysis of embryonic muscle in a local breed \[[@CR8]--[@CR10]\]. Although the importance of embryonic muscle and IMF development was established, underlying molecular mechanisms remain poorly understood.

The Beijing-you (BJY) chicken, called Beijing-fatty chicken, is an indigenous breed in China with good meat quality \[[@CR11], [@CR12]\]. When compared with fast-growing commercial broilers, the BJY is favored by local consumers because of the taste, rich fragrance, and tenderness of the meat. The Cobb is a famous genetically improved commercial line with excellent growth rate, and yield, especially of breast muscle. Breast muscle yield could reach more than 20% of live weight after D 28 ([www.Cobb-Vantress.com](http://www.cobb-vantress.com)), which is double that (around 10%) of BJY of similar live weight \[[@CR13]\].

With the aim of exploring the embryonic development-related proteome and metabolome signatures in breast muscle and its content of IMF, we quantitatively analyzed the proteomes and metabolomes of breast muscle of the two distinct chicken breeds at embryonic day12 (ED 12), ED 17, upon hatching (D 1) and day 14 post-hatching (D 14) using an Isobaric tags for relative and absolute quantitation (iTRAQ) and liquid chromatography/mass spectrometry (LC-MS) based approaches, and verified results from the discovery proteomics by Western blotting of selected proteins. Changing patterns of breast muscle growth and IMF contents at these critical stages of development were also measured.

Results {#Sec2}
=======

Development of breast muscle and accumulation of intramuscular fat during mid-incubation to early post-hatch growth {#Sec3}
-------------------------------------------------------------------------------------------------------------------

The local BJY chickens had distinct breast muscle features when compared with Cobb chickens (the genetically improved broiler line). For the two pre-hatching periods examined, the main muscle growth period appeared to be from ED 12 to ED 17, where the weight increased 1.8 fold in BJY and 8.4 fold in Cobb (Table [1](#Tab1){ref-type="table"}). The fiber density increased marginally from ED 17 to D 1 in Cobb but decreased in BJY (Table [2](#Tab2){ref-type="table"}). That indicates the stronger capacity for hyperplasia in Cobb during the embryonic periods.Table 1Muscle weights at different stages in Beijing-You and Cobb chickens (g)\*ItemED 12ED 17D 1D 14BJY0.175 ± 0.009^D^0.310 ± 0.008^C^0.453 ± 0.022^B^6.588 ± 0.265^A^Cobb0.102 ± 0.006^D^0.565 ± 0.014^C^0.730 ± 0.025^B^26.190 ± 1.087^A^\*Different uppercase superscripts indicate significant differences within the row (*P* \< 0.01). On a within-day basis, all differences between two breeds were significant. *n* = 10 Table 2Characteristics of muscle fibers at different stages in Beijing-you and Cobb chickens\*TermBreedsTimeED 17D 1D 14Fiber diameter (μm)BJY6.85 ± 0.20^C^7.57 ± 0.14^B^22.87 ± 0.30^A^Cobb5.10 ± 0.04^B^4.84 ± 0.07^C^27.51 ± 0.42^A^Fiber cross-sectional area (μm^2^)BJY28.45 ± 1.42^C^36.58 ± 1.29^B^280.79 ± 6.49^A^Cobb16.70 ± 0.24^B^15.13 ± 0.42^C^425.79 ± 13.61^A^Fiber density (fibers/mm^2^)BJY29.01 ± 0.40^A^21.41 ± 0.29^B^3.04 ± 0.04^C^Cobb47.10 ± 0.80^A^51.54 ± 3.05^A^2.54 ± 0.04^B^**\***Different uppercase superscripts indicate significant differences (*P* \< 0.01) within the row. On a within-day basis, all differences between two breeds were significant.Muscle fibers at ED12 were too small to be reliably measured

As expected, the muscle growth post-hatching increased much faster than during the pre-hatching periods. The weight increased 14.6 fold in BJY and 35.9 fold in Cobb (Table [1](#Tab1){ref-type="table"}). Correspondingly, the diameters of breast muscle fibers in BJY chickens were markedly smaller and densities of fibers were accordingly greater than those of D 14 Cobb chickens; both variables differed significantly (*P* \< 0.01) between the breeds (Table [2](#Tab2){ref-type="table"}, Figs. [1](#Fig1){ref-type="fig"}, [2](#Fig2){ref-type="fig"}).Fig. 1Muscle fibers of the breast muscle stained with hematoxylin and eosin (H&E) in BJY (bar, 60 μm) Fig. 2Muscle fibers of the breast muscle stained with hematoxylin and eosin (H&E) in Cobb (bar, 60 μm)

The accumulation of IMF in breast muscle at ED 12, ED 17, hatching (D 1) and D 14 was apparent from Oil red O staining (Figs. [3](#Fig3){ref-type="fig"}, [4](#Fig4){ref-type="fig"}). The maximal content of IMF was observed at D 1 in both BJY and Cobb, indicating that the earliest period of IMF accumulation was from ED 17 to D 1. No detectable fat was observed at D 14 showing that IMF was depleted dramatically between D 1 and D 14. It is worth noting that the major period for IMF accumulation (ED 17 to D 1) was exactly the opposite of when muscle growth occurred (ED 12 -- ED 17 and D 1 -- D 14).Fig. 3Oil red O staining of breast muscle tissues in BJY at early growth stages (bar, 30 μm) Fig. 4Oil red O staining of breast muscle tissues in Cobb chickens at early growth stages (bar, 30 μm)

Comparative proteomic and metabolomics analysis of breast muscle during mid-incubation to early post-hatch growth {#Sec4}
-----------------------------------------------------------------------------------------------------------------

A total of 2502 proteins were identified in the BJYs from 30,958 peptides and 2264 proteins were identified in the Cobbs from 28,456 peptides according to the standard (FDR less than 1%) of protein identification (Additional file [1](#MOESM1){ref-type="media"}: Table S1).

Because muscle development proceeds with temporal precision, focus was placed on proteins which differed significantly in abundance between the sequential sampling stages (ED 12 vs ED 17, ED 17 vs D 1 and D 1 vs D 14) in the two breeds. A full list of the quantified proteins and their mean fold-changes of the pairwise comparisons (each with two sub-sample pools) and the corresponding *P*-values is given in Additional file [2](#MOESM2){ref-type="media"}: Table S2. According to the criteria stated earlier, a total of 268 and 255 proteins showed significant differential abundance (DA) in BJY and Cobb; they are listed in Table [3](#Tab3){ref-type="table"}.Table 3The number of differentially abundant proteins and metabolites in Beijing-you and Cobb chickensStage ComparisonBeijing-youCobbProteinMetaboliteProteinMetaboliteED12-ED1792479555ED17-D199419257D1-D1477526857

In both breeds, ED 12 to ED 17 and D 1 to D 14 were the main periods for pre- and post-hatching muscle growth (Figs. [1](#Fig1){ref-type="fig"}, [2](#Fig2){ref-type="fig"}). There was, however, little overlap in differential abundance (DA) proteins between those two stages. For ED 12 to ED 17, the 92 and 95 DA proteins in BJY and Cobb that significantly changed in abundance (Table [2](#Tab2){ref-type="table"}) did not differ between D 1 and D 14, except for two in Cobb). For D 1 to D 14, where striking post-hatching muscle growth occurred, the 77 and 68 DA proteins in BJY and Cobb that significantly changed in abundance (Table [3](#Tab3){ref-type="table"}) differed for the two breeds and did not differ before hatching (Fig. [5](#Fig5){ref-type="fig"}).Fig. 5The number of differentially abundant proteins between the sequential sampling stages (ED 12 vs ED 17, ED17 vs D 1 and D 1 vs D 14) in BJY and Cobb chickens

A total of 41--52 metabolites in the BJYs and 55--57 metabolites in the Cobbs were identified as being differentially abundant according to the discriminating criteria (Table [3](#Tab3){ref-type="table"} and Additional file [3](#MOESM3){ref-type="media"}: Table S3).

Identification and pathway analysis of the differentially abundant proteins and metabolites for breast muscle {#Sec5}
-------------------------------------------------------------------------------------------------------------

DA proteins and DA metabolites at stages ED 12 -- ED 17, ED 17 -- D 1 and D 1 -- D 14 were subjected to integrative analysis within each breed (Additional file [2](#MOESM2){ref-type="media"}: Tables S2, and Additional file [3](#MOESM3){ref-type="media"}: Table S3). Results were focused on significant pathways related to at least two developmental stages.

**For the BJY chickens**, there were more than two DA proteins and metabolites participating in 14 significant pathways (Table [4](#Tab4){ref-type="table"}). Six pathways were enriched during the entire interval (ED12-D14) examined in the current study, including FXR/LXR/RXR Activation, Actin Cytoskeleton Signaling, TCA Cycle II.Table 4The pathways and related differentially abundant proteins and metabolites for breast muscle in Beijing-You chickens^a^PATHWAYED 12 - ED 17ED 17 - D 1D 1 - D 14FXR/RXR Activation, LXR/RXR ActivationSERPINA1, COL3A1, RBP4, androsteroneAPOB, C3, APOA1, VTN, GCKNG1, C3, APOA1, TF, VTN, AHSG, GC, androsteroneCalcium SignalingMYH2, TNNI2, TPM1, MYH7B, MYL1, CASQ2MYH10, MYH2, MYH9, TNNC2, TNNT3, ATP2A2MYH2, acetylcholine, TNNC1Actin Cytoskeleton Signaling, Tight Junction SignalingMYH2, MYL10, FLNA, ACTN2, MYH7B, MYL1MYH10, MYH2, MYH9, ACTN2KNG1, MYH2, acetylcholine, F2Clathrin-mediated Endocytosis SignalingHSPA8, SERPINA1, RBP4SH3GL1, APOB, APOA1APOA1, TF, F2Unfolded protein response, Protein Ubiquitination PathwayHSPA8, HSPA4, HSPA9, HSPA2, HSP90AA1, FKBP4HSP90B1, HSPA5P4HB, VCPTCA Cycle II (Eukaryotic)ACO2, succinic acidSDHA, SUCLA2, L-malic acid, ACO2, IDH3A, MDH2, OGDH, succinic acidL-malic acid, succinic acidProtein Kinase A SignalingGNB1, prostaglandin E2, MYH2, MYL10, TNNI2, FLNA, RACK1, MYL1--prostaglandin E2,MYH2, YWHAE, PDIA3, YWHAZ, PPP1R3A, PHKG1Purine Nucleotides Degradationinosine, hypoxanthine,--guanine, inosine, hypoxanthine, guanosineAcute Phase Response Signaling--PLG, C3, APOA1PLG, C3, APOA1, TF, AHSG, F2Glycolysis I/ Gluconeogenesis I--PGK1, L-malic acid, MDH2PGK1, GPI, L-malic acid, PGAM1, ENO2, GAPDH, BPGM, FBP2PPARγ/RXR Activation--HSP90B1, ACADL, APOA1, PDIA3, GOT2ACADL, APOA1, PDIA3Superpathway of Methionine Degradation--BHMT, MAT1A, GOT1, GOT2betaine, AHCYCoagulation System--PLG, SERPINC1KNG1, PLG, F2Hypoxia Signaling in the Cardiovascular System--HSP90B1, LDHAP4HB, LDHA^a^-means no differentially abundant proteins and metabolites enriched

Different from the Cobbs, seven proteins related to Unfolded protein response and Protein Ubiquitination Pathway, including HSPA8, HSPA4, HSPA9, HSPA2, HSP90AA1, FKBP4, were enriched specifically in embryonic BJY and this pathway might play an important role from ED 12 until D 14. Six pathways were enriched during ED 17 to D 14, including Glycolysis I/Gluconeogenesis I and PPARγ/RXR Activation. It is worth noting that five proteins enriched in PPARγ/RXR Activation started to express differentially as early as ED 17, including ACADL, which might contribute to the fast accumulation of embryonic IMF. Pathways related to Purine metabolism were enriched as well.

**For Cobb chickens,** there were two to eight DA proteins and metabolites participating in 10 significant pathways (Table [5](#Tab5){ref-type="table"}). Four pathways were enriched throughout (ED 12 -- D 14), including FXR/LXR/RXR Activation, Calcium Signaling and Glycolysis I/Gluconeogenesis I. Of special interest, as many as seven DA proteins and metabolites, viz. NDUFS1, ATP5B, UQCRC2, ACO2, VDAC1,VDAC2 and palmitic acid, were enriched in Oxidative Phosphorylation/Mitochondrial Dysfunction pathway during the embryonic stages studied; these might play roles in the rapid muscle growth (8.4 fold change from ED 12 -- ED 17) and increase in fiber density from ED 17 -- D 1. Global and breed-specific pathways for muscle development in local BJY and commercial Cobb chickens are indicated in Fig. [6](#Fig6){ref-type="fig"}.Table 5The pathways and key proteins and metabolites for breast muscle in Cobb chickens^a^PATHWAYED 12 - ED 17ED 17 -- D 1D 1 - D 14FXR/RXR Activation, LXR/RXR ActivationAPOB, SERPINA1, COL3A1, FGALYZ, APOA1, APOH, androsteroneALB, TF, APOH, GC, androsteroneCalcium SignalingMYH2, TNNI2, acetylcholine, TPM1, CASQ2, ACTA1TNNI2, TNNC2, TNNC1, TPM1, ATP2A2, CASQ2MYH2, acetylcholine, TNNC1Actin Cytoskeleton SignalingTLN2, MYH2, MYL10, acetylcholine, TLN1, ACTA1FN1, FLNA, ACTN2MYH2, acetylcholine, ARPC3, GSNGlycolysis I/ Gluconeogenesis IENO1, MDH2PGAM1, MDH1, MDH2PGK1, GPI, PGAM1, GAPDH, FBP2TCA Cycle II (Eukaryotic)ACO2, DLD, FH, MDH2ACO2, MDH1, FH, MDH2, OGDH--Oxidative Phosphorylation/ Mitochondrial DysfunctionNDUFS1, ATP5B, UQCRC2, ACO2, VDAC1, palmitic acid, VDAC2ATP5B, ACO2, NDUFB6, OGDH, palmitic acid, ATP5F1, VDAC2Hepatic Fibrosis / Hepatic Stellate Cell ActivationMYH2, COL6A1, COL6A2, COL20A1, COL3A1--MYH2, COL4A1, COL12A1Acute Phase Response Signaling--FN1, APOA1, APOHALB, TF, APOHProtein Kinase A Signaling--prostaglandin E2, TNNI2, FLNA, PDIA3, PYGBprostaglandin E2, PHKB, MYH2, YWHAE, YWHAZ, PYGBClathrin-mediated Endocytosis Signaling--SH3GL1, LYZ, APOA1ALB, TF, ARPC3^a^-means no differentially abundant proteins and metabolites enriched Fig. 6Global and breed-specific pathways for early muscle and IMF development in local BJY and commercial Cobb chickens. Stage information for each enriched pathway was given where ED 12 means embryonic day 12; ED 17 means embryonic day 17; D 1 is the hatching day and D 14 is the day 14 post-hatching; symbol \* means the pathway was enriched at different stages in different breeds; key proteins and metabolites which mediated each pathway can be found in Tables [4](#Tab4){ref-type="table"} and [5](#Tab5){ref-type="table"}; Beta-oxidation (mitochondria) of fatty acid pathway was enriched for IMF accumulation in both breeds

Although large differences exist between two breeds at different stages in terms of growth rate or developmental process, it supplied good chance to explore common signatures at molecule level for muscle development in chicken. The common proteins or metabolites involved in common pathways for both breeds were focused.

There were eight DA proteins and two DA metabolites that might be necessary for muscle development during the middle embryonic period (ED 12 - ED 17), including MYH2, TPM2 and inosine (Table [6](#Tab6){ref-type="table"}). The 14 DA proteins and three DA metabolites for muscle during the late embryonic period (ED 17 -- D 1), included ACADL, ATP5bB, and palmitic acid (Table [7](#Tab7){ref-type="table"}); finally 13 DA proteins and five DA metabolites for muscle were identified during early post-hatch growth (D 1 -- D 14), included GAPDH and acetylcholine (Table [8](#Tab8){ref-type="table"}).Table 6Important proteins and metabolites playing roles in muscle development during the embryonic period (ED 12 - ED 17)^a^IDProtein/Compound NameGene NameBJY Fold changeCobb Fold changePathwaygi\|45,383,668Myosin-3MYH211.528.47Actin Cytoskeleton Signalinggi\|148,225,102Myosin Regulatory light chain 2BMYL100.330.21Actin Cytoskeleton Signalinggi\|478,246,981Serpin peptidase inhibitor, clade A, member 4 precursorSERPINA10.330.50FXR/RXR Activationgi\|206,597,436Collagen alpha-1(III) chain precursorCOL3A17.0528.30FXR/RXR Activationgi\|45,383,738Aconitate hydrataseACO24.764.53TCA cyclegi\|45,382,253Troponin I, fast skeletal muscleTNNI218.8320.34Calcium Signalinggi\|45,382,323Tropomyosin alpha-1 chainTPM115.0799.08Calcium Signalinggi\|46,093,996Calsequestrin-2 precursoCASQ29.426.96Calcium SignalingHMDB00195inosine--18.0049.86Purine Nucleotides metabolismHMDB00292hypoxanthine--8.5722.47Purine Nucleotides metabolism^a^- means no differentially abundant proteins and metabolites a a enriched Table 7Important proteins and metabolites playing roles in muscle development during the late embryonic period (ED 17 -- D 1)IDProtein/Compound nameGene nameBJY (FC)Cobb (FC)Pathwaygi\|45,382,961Apolipoprotein A-I preproproteinAPOA13.053.55FXR/RXR Activationgi\|45,384,348Aspartate Aminotransferase, cytoplasmicGOT13.044.09Amino acid metabolismgi\|45,383,117Endophilin-A2SH3GL10.390.39Endocytosis Signalinggi\|448,261,627Mitochondrial ATP Synthase Beta SubunitATP5B2.962.51Oxidative Phosphorylationgi\|363,743,079ATP synthase subunit b, mitochondrialATP5F13.041.72Oxidative Phosphorylationgi\|45,383,738Aconitate hydrataseACO23.003.13Oxidative Phosphorylationgi\|45,383,562Endoplasmin precursorHSP90B10.390.43PPARγ/RXR Activationgi\|57,529,797Long-chain specific acyl-CoA dehydrogenase, mitochondrialACADL2.152.30PPARγ/RXR Activationgi\|45,383,890Protein disulfide-isomerase A3 precursorPDIA30.480.49PPARγ/RXR Activationgi\|50,758,110Malate dehydrogenase, mitochondrialMDH24.211.59TCA Cyclegi\|71,897,2932-oxoglutarate dehydrogenase, mitochondrialOGDH3.122.72TCA Cyclegi\|45,382,067Troponin C, skeletal muscleTNNC22.352.35Calcium Signalinggi\|430,736,679Endoplasmic reticulum calcium ATPase 2 isoform 1ATP2A23.034.58Calcium Signaling Table 8The differentially abundant proteins and metabolites playing roles in muscle development during early post-hatchling growth (D 1 -- D 14)^a^IDProtein/Compound nameGeneBJY (FC)Cobb (FC)Pathwaygi\|45,384,486Phosphoglycerate kinasePGK13.2914.51Glycolysis Igi\|57,524,920Glucose-6-phosphate isomeraseGPI6.875.49Glycolysis Igi\|45,382,061Triosephosphate isomeraseTPI15.935.14Glycolysis Igi\|71,895,985Phosphoglycerate mutase 1PGAM112.897.46Glycolysis Igi\|46,048,961Glyceraldehyde-3-phosphate dehydrogenaseGAPDH1.761.93Glycolysis Igi\|347,800,7286-phosphofructokinasePFKM7.458.14Glycolysis Igi\|50,762,391Fructose-1,6-bis phosphatase isozyme 2FBP217.1011.04Glycolysis Igi\|45,382,425vitamin D-binding protein precursorGC0.180.19FXR/RXR ActivationHMDB00031androsterone--0.0341.28E-07FXR/RXR Activationgi\|45,384,092Troponin C, slow skeletal and cardiac muscleTNNC122.5722.67Calcium SignalingHMDB00895acetylcholine--39.1224.42Calcium Signalinggi\|55,741,61614--3-3 protein epsilonYWHAE0.250.16Protein Kinase A Signalinggi\|71,897,03514--3-3 protein zetaYWHAZ0.210.20Protein Kinase A Signalinggi\|513,217,491AdenosylhomocysteinaseAHCY0.180.16Methionine Degradationgi\|45,385,813Ovotransferrin precursorTF0.170.21Acute Phase Response SignalingHMDB00254succinic acid--5.9840.80TCA Cycle IIHMDB00062L-carnitine--7.1619.03L-carnitine BiosynthesisHMDB00220palmitic acid--1.682.28Mitochondrial Dysfunction/Stearate Biosynthesis I^a^- means no differentially abundant proteins and metabolites a enriched

Identification and pathway analysis of the differentially abundant proteins related to IMF {#Sec6}
------------------------------------------------------------------------------------------

The major period of accumulation of IMF was from ED 17 to D 1 and it was then depleted dramatically between D 1 and D 14 (Figs. [3](#Fig3){ref-type="fig"}, and [4](#Fig4){ref-type="fig"}). DA proteins and metabolites with exactly consistent changing pattern with the changes in IMF across these two stages were found and proposed as being potentially important molecules for IMF. Eight proteins were significantly altered in abundance between ED 17 and D 1 with reciprocal changes occurring from D 1 to D 14 in both breeds (Table [9](#Tab9){ref-type="table"}). For example, abundant of several rate-limiting enzymes for mitochondrial beta-oxidation of fatty acid, ACADL, ACAD9, HADHA, HADHB, were increased before D1 and decreased from D1 to D14 (Fig. [6](#Fig6){ref-type="fig"}). Additionally, the changing pattern of the cholesterol transfer protein (APOA1), muscle related proteins (LAMA2 and TPM2) and calcium-binding protein (SRL) were consistent or opposite with those of IMF in both breeds.Table 9The differentially abundant proteins and metabolites playing roles in IMFIDProtein nameGene nameBJY (FC)^a^Cobb (FC)gi\|57,529,797Long-chain specific acyl-CoA dehydrogenaseACADL2.15/0.352.29/0.35gi\|45,382,961Apolipoprotein A-I preproproteinAPOA13.05/0.033.55/0.05gi\|45,384,238Trifunctional enzyme subunit alphaHADHA2.20/0.322.17/0.21gi\|513,179,326Trifunctional enzyme subunit betaHADHB3.28/0.291.80/0.35gi\|57,524,955Acyl-CoA dehydrogenase family member 9, mitochondriaACAD92.39/0.312.71/0.34gi\|45,384,504Sarcalumenin precursorSRL2.33/0.362.17/0.21gi\|513,177,212Laminin subunit alpha-2LAMA22.03/0.452.45/0.29gi\|45,382,083Tropomyosin beta chainTPM22.35/0.252.56/0.34^a^Fold change between ED 17 -- D 1 and / that between D 1 -- D 14 are shown

Validation of DA proteins with western blotting {#Sec7}
-----------------------------------------------

Western blotting of several proteins was used to verify the DA protein profiles obtained by the iTRAQ analyses. Selection was based on the biological functions and the protein profiles. Four proteins (PKM2, GAPDH, DES and ATP5B) were candidates for muscle development; two proteins (ACADL and TPM2) were related to IMF, and the rest were selected randomly. The results showed acceptable consistency between the quasi-quantitative Western blots and the fold-changes of DA proteins from the iTRAQ analysis (Figs. [7](#Fig7){ref-type="fig"} and [8](#Fig8){ref-type="fig"}).Fig. 7Comparison between levels of TPM2, ACADL, ATP5B, GAPDH, DES determined by Western blotting and iTRAQ in BJY. HSP70 was used as the reference protein Fig. 8Comparison between levels of TPM2, PKM2, ATP5B, ACADL, GAPDH, DES determined by Western blotting and iTRAQ in Cobb. HSP70 was used as the reference protein

Discussion {#Sec8}
==========

Chickens are among the most important food animals of worldwide economic significance and are widely used as a model species for the study of embryonic development. To our knowledge, no study has systematically examined the proteomes and metabolomes of embryonic skeletal muscle and IMF development.

In the current study, obvious phenotypic patterns exist both in slow-growing BJY and fast-growing Cobb chickens which are in line with the three critical stages in muscle development: ED 12 to ED 17 (embryonic rapid growth, hyperplasia), ED 17 to D 1 (hyperplasia and embryo preparing for hatch), D 1 to D 14 (shift from myoblast-mediated growth to satellite cell-mediated growth by hypertrophy) \[[@CR5], [@CR6], [@CR14]\].

For muscle development, interest centered on the striking divergence of slow-growing and fast-growing birds and the underlying molecular basis for it. Breast muscle mass during middle-embryo and post-hatch stages was dramatically increased, which was in accordance with that observed in previous reports \[[@CR15], [@CR16]\]. In the BJY with no history of genetic selection for pectoral muscle size, the muscle weight increased 1.8 fold during the hatchling period accompanied by increasing fiber diameter and fiber cross-sectional area (could not be measured for ED 12 reliably). The fiber diameter and fiber cross-sectional area decreased from ED 17 -- D 1 in Cobb. Correspondingly, the fiber density increased marginally from ED 17 -- D 1 in Cobb but decreased significantly in BJY. That indicated the growth of the embryonic muscle weight in Cobb is mainly a result of stronger hyperplasia process instead of hypertrophy, which contribute to the post-hatchling excellent muscle mass achievements in fast-growing Cobb (35.9 fold change from D 1 to D 14).

For deposition of IMF in chicken embryo, this study is the first to show that the major time for accumulation of embryonic IMF was from ED 17 to D 1, the period when muscle growth was the least; the striking muscle growth occurred after D 1 (D 1 -- D 14). These observed phenotypic patterns were supported by the proteomic and metabolomic profiles of breast muscle evident at ED 12, ED 17, D 1 and D 14 in the two breeds.

For proteomic profiling, mass spectrometry (MS)-based proteomics were applied by the 8-plex iTRAQ strategy, where each plex using two protein pools (*n* = 5 individuals). Pooling strategy with two biological replicates was applied, as suggested by Gan et al., (2007), which has the potential advantage of decreasing overall variability due to differences between individuals \[[@CR17]\]. The correlation between DA fold changes for proteins in the two replicates were all high (R^2^ \> 0.94, Additional file [4](#MOESM4){ref-type="media"}: Figures S1, and S2). The consistency between the quasi-quantitative Western blots and the changing pattern of DA proteins from the iTRAQ analysis were acceptable. As metabonomics reflects, in part, the downstream consequence of proteomics, it is also regarded as the complement of other "omics" for interpretation of functional genomics \[[@CR18]\]. For metabolomic profiling in the current study, ten biological replicates for each age were from the same batch of chickens used for proteomic profiling. The advantage of combined proteomic and metabolomic profiling is that more profound results could be acquired than independent proteome analysis.

Through analysis of DA proteins and metabolites in the context of development, a remarkable finding is that, for embryonic Cobbs, many DA molecules (NDUFS1, ATP5B, UQCRC2, ACO2, VDAC1, VDAC2 and palmitic acid) were concentrated in Oxidative Phosphorylation/Mitochondrial Dysfunction pathway; those are vital for energy generation and metabolism (Tables [5](#Tab5){ref-type="table"}, [7](#Tab7){ref-type="table"}, [8](#Tab8){ref-type="table"}) \[[@CR19]--[@CR22]\]. The network analyses (Additional file [4](#MOESM4){ref-type="media"}: Figure S3) were consistent with the energy requirement being greater for the faster muscle growth of the Cobbs. ATP5B is the catalytic subunit of the rate-limiting enzyme of oxidative phosphorylation and its abundance increased from ED 12 -- ED 17 in Cobbs, as shown by Western blotting (Fig. [7](#Fig7){ref-type="fig"}).

Different from the Cobbs, in BJY, numerous proteins related to protein processing (HSPA8, HSPA4, HSPA9, HSP90AA1 and FKBP4) showed highest abundance at ED 12 and decreased thereafter (Additional file [4](#MOESM4){ref-type="media"}: Figure S4). As chaperones, heat shock proteins are known to aid in the folding of newly synthesized proteins and have roles in the disaggregation and degradation of persistently misfolded proteins \[[@CR23]\]. The similar changing pattern of molecular abundance in Purine metabolism pathways (inosine and xanthine), indicated that genetic information processing might be more active in the embryonic development of slow-growing breeds. Findings from this study, especially on the metabolites in the faster growing Cobbs, might supply extra evidence for Oliveira's hypothesis that high yield meat birds may direct more caloric resources towards muscle growth than towards fueling the hatching process \[[@CR14]\].

Specific for BJY chickens, a series of DA proteins (ACADL, APOA1, HSP90B1, PDIA3 and GOT2) were enriched in PPAR signaling after ED 17 (Tables [4](#Tab4){ref-type="table"}, [7](#Tab7){ref-type="table"}, [8](#Tab8){ref-type="table"}), among which the increase in ACADL, verified by Western blotting, changing in a manner that is consistent with those of IMF from ED 17 to D 14. Recent studies proved that PPARs functions as a key regulator for adipocyte development and IMF regulation \[[@CR9], [@CR24], [@CR25]\]. Those proteins might contribute to the high capacity for accumulation of IMF in BJY chickens. The high abundances of ACADL at D 1 compared to post-hatchling days were consistent with previous reports \[[@CR8], [@CR26]\]. The most obvious fat accumulation at ED 17 -- D 1 was also supported by the most significant IPA network constructed from DA proteins and metabolites between ED 17 and D 1, in which 29/34 proteins were detected and enriched (Additional file [4](#MOESM4){ref-type="media"}: Figure S5). It is worth noting the role of the methionine pathway in early muscle development. Key enzyme proteins for methionine degradation were decreased from ED17 to D 14, including MAT1A, BHMT or AHCY (Tables [4](#Tab4){ref-type="table"}, [8](#Tab8){ref-type="table"}). It is well established that MAT1A is the main gene responsible of S-adenosylmethionine (SAM) synthesis. Inhibition of AHCY can make S-adenosyl-homocysteine (SAH) accumulation, consequently suppressing the use of SAM for transmethylation reactions \[[@CR27]\]. BHMT is a methyl transferase that can catalyze the transfer of the methyl group from betaine to homocysteine, which supplies the methyl group to methylate DNA \[[@CR28]\]. A consistent finding in the present study was the decreased abundance of betaine from D 1 to D 14. Taken together, it indicated that the transmethylation reaction was attenuated from ED 17 to D 14 in BJY, which might contribute to the little overlap found in DA proteins between periods for pre- and post-hatching muscle growth (ED 12 - ED 17 vs D 1 - D 14). Considering that the abundance of AHCY and BHMT were also decreased in Cobb from D1 to D 14, further study is needed to clarify the epigenetic changes underlying altered protein abundance in early stages of chicken muscle and IMF development.

For the common features between the two breeds, several pathways, key proteins and metabolites (Tables [6](#Tab6){ref-type="table"}, [7](#Tab7){ref-type="table"}, [8](#Tab8){ref-type="table"}) are known to be involved in muscle development. Some pathways, including FXR/RXR and LXR/RXR Activation, Calcium Signaling, Glycolysis I/Gluconeogenesis I, TCA Cycle II and Actin Cytoskeleton Signaling, were enriched in more than two stages. It was interesting that the abundance of androsterone, a weak androgen, decreased from D 1 to D 14 in both breeds. As an activator of the nuclear hormone receptor farnesoid X receptor (FXR) \[[@CR29]\], the changing pattern is consistent with that of the FXR/RXR activation pathway, which was inactive from D 1 -- D 14. Additionally, consistent with the increased protein abundance of TCA cycle enzymes, including ACO2 and/or MDH2, there were increases in L-malic acid (in BJY from ED 17 to D 14) and succinic acid (in both breeds from D 1 to D 14).

It is also worth noting the roles of the DA proteins enriched in Protein Kinase A Signaling in muscle development. Six to eight DA proteins and metabolites were enriched in that pathway in more than two stages in both breeds indicating the likelihood of their contributing to muscle glycogen metabolism. The breast muscle of the avian embryo is metabolically important mainly because of its large storage capacity for glycogen \[[@CR6]\]; an important source of energy for skeletal muscle. The enriched proteins included YWHAE and YWHAZ, which belong to the 14--3-3 family of proteins, and were found to decrease from fast growing stages (D 1 - D 14) in both breeds. That is perhaps consistent with the report that YWHAE inhibited hypertrophy of cardiomyocytes \[[@CR30]\]. Additional study of the function and mechanism of action of 14--3-3 proteins in development of skeletal muscle is needed. Acute Phase Response Signaling was also enriched in both breeds from ED 17 to D 14. The abundance of most of the enriched proteins, including APOA1 and APOH in Cobbs and PLG, C3 and APOA1 in BJY showed reciprocal changes between ED 17 -- D 1 and D 1 -- D 14 similar to that of IMF content. The function of complement C3 precursor has been reported to relate to insulin secretion and glucose homeostasis \[[@CR31]\], but its possible relationship with IMF has not been described.

As for IMF accumulation, according to the findings in cattle, the level of IMF at the start of the growth period is likely a key determinant of the final level of IMF after finishing \[[@CR32]\]. In chickens, the early period of change in IMF was observed between ED 17 and D1, when changes in muscle growth were least obvious. This suggested that myocytes and adipocytes influencing each other during development. The accretion rate of IMF depends on the number of adipocytes and their net accumulation of stored lipid. Aspects of muscle growth and its metabolic activity are also important. For example, animals having a high muscularity with a high glycolytic activity display a reduced development of IMF \[[@CR2]\]. In the current study, several proteins altered in abundance between ED 17 and D 1 and reciprocal changes were demonstrated from D 1 to D 14 and this changing pattern was exactly consistent with the changes in IMF. Of special interest, four were rate-limiting enzymes for mitochondrial beta-oxidation of fatty acid (ACADL, ACAD9, HADHA, HADHB), which highlight the important role of this pathway playing in IMF accumulation at early stage. The ACADL catalyze the initial step of mitochondrial beta-oxidation of straight-chain fatty acid and its changes from iTRAQ analyses were verified by Western blotting. The results were consistent with previous report that lipid oxidation was very active from mid incubation until 2 or 3 days before internal pipping because adequate oxygen and yolk fatty acids could be supplied. Additionally, the abundant of apolipoprotein A1 was increased from D12 to D1, which might contribute to lipoproteins taking up cholesterol from the yolk sac membrane \[[@CR14]\]. Consistent with Cui's report \[[@CR9]\], genes and pathways related to muscle development and ECM were also involved in IMF deposition, including the muscle related protein LAMA2 \[[@CR33]\], an extracellular protein TPM2 \[[@CR34]\] and the calcium-binding protein SRL \[[@CR35]\]. The changes in TPM2 from iTRAQ analyses were verified by Western blotting. As it is difficult to quantify IMF content during embryonic development in chickens, it emphasizes the utility of suitable bio-markers.

Conclusion {#Sec9}
==========

In summary, this study found that ED 17 - D 1 was the earliest period for IMF accumulation. Through integrated analysis of the protein and metabolite profiles of breast muscle, pathways related to protein processing and PPAR signaling were found to be enriched to support high capacity of embryonic IMF accumulation in Beijing-You. Pathways related to ATP production were enriched to support the fast muscle growth in Cobb. Mitochondrial beta-oxidation of fatty acid is identified as the key pathway related to chicken IMF deposition at early stages.

Methods {#Sec10}
=======

Animals {#Sec11}
-------

The Beijing-You (BJY) and Cobb-Vantress (Cobb) eggs were obtained from the experimental farm of the IAS (CAAS, Beijing, China) and the Anhui five-star cultivation group CO. LTD (Ningguo, China). All eggs were incubated with the normal procedure and chicks were reared in caging under continuous lighting using standard conditions of temperature, humidity and ventilation at the farm of the IAS, CAAS. Chickens used for sample collection at D 1 were not fed. The same diet was fed to all chickens and was formulated to be intermediate between recommendations for the two breeds \[[@CR36], [@CR37]\]. The starter ration (D 1 to D 21) provided 20% crude protein and 2.87 MCal/kg energy. Feed and water were provided ad libitum*.*

Tissue sampling {#Sec12}
---------------

Breast muscles were collected from embryos at ED 12 and ED 17 or chicks of similar weights at D 1 and D 14 within each breed. Chicks were electrically stunned and killed by exsanguination. Because of the limited amount of sample from each bird, especially during the embryonic stages, 10 embryos or birds with similar egg/body weight were used for protein analysis, an additional 10 for histology and 10 for metabolomic analysis. The embryos, bodies and breast muscles on both sides were weighed. Sub-samples were immediately fixed in 4% paraformaldehyde and held at room temperature and additional samples were snap frozen in liquid nitrogen and held at −80 °C. The latter samples were used for the iTRAQ, UHPLC--MS, Western blotting and oil red O staining.

Histology {#Sec13}
---------

Two or three serial cross-sections of five randomly selected chickens per age in the two breeds were used to evaluate the area, diameter and density of muscle fibers (stained with hematoxylin and eosin) and oil red O staining. Fixed tissues were dehydrated through an ascending ethanol series, embedded in paraffin, and sectioned (3--5 μm). After dewaxing in xylene and rehydration using a descending alcohol gradient, mounted muscle sections were stained with hematoxylin and eosin (H&E). Oil red O staining was as follows: frozen sections (4--8 μm) were air dried for 15--20 min then immersed in 100% isopropanol for 5 min, 0.5% working solution of oil red O for 7--8 min then 85% isopropanol for 3 min. Thereafter, sections were washed with three exchanges of deionized water and counterstained with hematoxylin for 1--1.5 min to visualize nuclei. Sections were rinsed with running tap water for 10 min and covered with a coverslip using 10% glycerol in PBS. Images were captured and processed with Image-Pro Plus 6.0 software.

Protein extraction and quantitation {#Sec14}
-----------------------------------

The muscle samples obtained at four ages from the two breeds were ground to powder in liquid nitrogen and dissolved in lysis buffer (9 M urea, 4% CHAPS, 1% DTT, 1% IPG buffer) at 30 °C for 1 h. The supernatants, obtained by centrifugation at 15,000 *g* for 15 min at room temperature, were re-centrifuged. Protein concentrations of the supernatants were then determined by the Bradford method. For each age and breed, two pools were constructed using equal amounts of protein from five of the 10 sampled individuals. Each pool was then diluted to the same concentration with TBS for iTRAQ labeling and then stored at −80 °C until analysis.

Protein digestion and iTRAQ labeling {#Sec15}
------------------------------------

The two protein pools, representing biological replicates at each stage and breed, were used to determine the protein profiles. After precipitation with acetone, protein pellets were dissolved in the buffer from the iTRAQ kit (Sigma, St Louis, MO). Each sample was then reduced, alkylated, digested with trypsin, and labeled with the iTRAQ reagents as follows: each protein pellet for eight samples was reduced with 4 μL reducing reagent, incubated at 60 °C for 1 h, alkylated with 2 μL cysteine blocking reagent, and incubated at room temperature for 10 min. Trypsin digestion used 2.5 μg sequencing-grade trypsin (Promega, Madison, WI) and incubating the samples at 37 °C for 12 h. The peptides were precipitated and collected by centrifugation at 15,000 *g* for 20 min, then dissolved in 50 μL dissolution buffer and re-centrifuged.

The labeling was 2-plex for the two pools at each age and breed. For BJY, reporter tags 117/118, 115/116, 113/114, 119/121 were used for samples from ED 12, ED 17, D 1 and D 14, respectively. For the Cobbs, iTRAQ labeling used 115/116, 113/114, 119/121, 117/118 for samples from ED 12, ED 17, D 1 and D 14, respectively. The labeled peptide samples were pooled within each breed (8-plex, 100 g total peptide) and fractionated by strong cationic exchange (SCX) chromatography.

2D--LC-MSMS analysis {#Sec16}
--------------------

Chromatographic separation of the pooled samples was performed on an Agilent 1200 HPLC system (Agilent Technologies Inc., Santa Clara, CA). Labeled peptides were fractionated by strong cation exchange liquid chromatograph (SCX) using a 2.0 × 150 mm, 5 μm, 300 Å column (Michrom, Auburn, CA). The samples were dissolved in 100 μL buffer A (10 mM ammonium formate (pH = 2.8) with 20% ACN). Separation was performed at 0.3 ml/min using a nonlinear binary gradient from buffer A to 50--100% buffer B (500 mM ammonium formate (pH = 2.8) with 20% ACN) over 40 min, and 30 to 100% buffer B for 5 min. A total of 12 fractions were collected. The first fraction was collected from 0 to 5 min, and then 4 min fractions were collected from 6 to 44 min, and a final fraction from 45 to 50 min. Each fraction was vacuum freeze-dried for LC-MSMS analysis.

RPLC-MSMS analysis {#Sec17}
------------------

Fractions were dissolved in Nano-RPLC Buffer A (0.1% formic acid, 2% ACN). The online Nano-RPLC was employed on the Eksigent nanoLC-Ultra™ 2D System (SCIEX, Framingham, MA). The samples were loaded on a C18 nanoLC trap column (100 μm × 3 cm, C18, 3 μm, 150 Å) and washed with Nano-RPLC Buffer A (0.1% formic acid, 2% ACN) at 2 μL/min for 10 mins. Elution used a gradient of 5% to 35% Nano-RPLC buffer B (0.1% formic acid, 98% ACN) over 70 min using an analytical ChromXP C18 column (75 μm × 15 cm, C18, 3 μm 120 Å) with spray tip. Data was acquired by the Triple TOF 5600 System (SCIEX) fitted with a Nanospray III source (SCIEX) and a pulled quartz tip as the emitter (New Objective, Woburn, MA). The ion spray voltage of the mass spectrometer was set to 2.5 kV, the curtain and nebulizer gases were set to 30 psi and 5 psi, respectively, and the heated capillary temperature was set to 150 °C. Survey scans were acquired in 250 ms using the information dependent acquisition. Up to 35 product ion scans were collected if they exceeded 150 counts per second (counts/s) with a 2^+^ − 5^+^ charge-state. The total cycle time was fixed at 2.5 s. For collision-induced dissociation, a rolling collision energy setting was used to all precursor ions. A dynamic exclusion time was set for 1/2 of peak width (18 s). The precursor was then refreshed off the exclusion list.

Differential abundance (DA) protein identification and quantification {#Sec18}
---------------------------------------------------------------------

The raw peptide, protein identification and quantification were performed using Protein Pilot v4.0 (SCIEX) against the chicken database with the Paragon algorithm \[[@CR38]\]. Search parameters were set as follows: instrument was TripleTOF 5600, iTRAQ 8-plex quantification, trypsin as enzyme, fixed modification of cysteine by iodoacetamide, biological modification as the ID focus, thorough identification search. To reduce false positive identification, false discovery rate (FDR) less than 1% was required for all reported proteins by PSPEP (Proteomics System Performance Evaluation Pipeline Software, integrated into the Protein Pilot software). Proteins with \> \|1.5\| -fold differences between coupled samples and *P*-value of less than 0.05 were determined as having differential abundance.

Metabolomic sample preparation and quantitation {#Sec19}
-----------------------------------------------

Breast muscle samples from 10 birds in BJY and Cobb at four different ages were prepared by powdering the tissue in liquid nitrogen. Sample (0.1 g) was mixed with 500 μL of 50% aqueous acetonitrile (Merck, Darmstadt, Germany) and centrifugation at 12,000 *g* and 4 °C for 15 min to eliminate the proteins. Supernatant (200 μL) was removed and diluted with 100 L acetonitrile (Merck, Darmstadt, Germany), then vortexed for 5 min. After centrifuging at 12,000 *g* and 4 °C for 10 min, the clear supernatant was transferred to the sampling vial and an aliquot of 80 μL was injected for UHPLC--MS analysis.

UHPLC-MS analysis {#Sec20}
-----------------

UHPLC-MS analysis was performed on a 1290 Infinity LC system equipped with 6520 Accurate-Mass Quadrupole Time-of-Flight (Q-TOF) mass spectrometer (Agilent). Chromatographic separations were performed at 40 °C on a Waters ACQUITY UPLC HSS T3 column (2.1 mm × 100 mm, 1.8 μm, Milford, MA).The mobile phase consisted of 0.1% formic acid - water (A) and 0.1% formic acid - ACN (B). The optimized elution started from 5% buffer B at 0--2 min and increased to 95% buffer B between 2 and 17 min, then held at 95% buffer B for 2 min, followed by re-equilibrating for 6 min. The flow rate was 0.4 mL/min and the injection volume was 4 μL. The autosampler was maintained at 4 °C.

### LC/MS analysis {#Sec21}

An electrospray ionization source (ESI) was applied in positive and negative mode. The optimized parameters were set up as follows: capillary voltage, 4 kV for positive mode and 3.5 kV for negative mode; nebulizer pressure, 45 psig (310.3 kPa); drying gas flow, 11 L/min; gas temperature, 350 °C; fragmentor voltage, 120 V; skimmer voltage, 60 V. Data were acquired in centroid mode from 50 to 1100 m/z.

### DA metabolite identification {#Sec22}

Each sample was represented by a total ion current chromatogram. Agilent MassHunter Qualitative software was applied to convert the UHPLC--MS raw data to common data format files. The program XCMS (<http://enigma.lbl.gov/xcms-online/>) was used for peak detection, RT alignment and peak integration to generate a visual data matrix. The data of each sample were loaded to SIMCA-P software (MKS Umetrics, Umea, Sweden) for partial least squares-discriminate analysis. Statistically significant differences between mean values of two groups were tested by Student T-test in SPSS 19.0. The differences were considered significant when VIP (Variable Importance in the Projection) value \>1 and *P* \< 0.05.

Integrated analysis of DA proteins and metabolites with IPA analysis {#Sec23}
--------------------------------------------------------------------

Ingenuity Pathway Analysis (IPA; Ingenuity Systems, Redwood City, CA; <https://www.qiagenbioinformatics.com/products/ingenuity-pathwayanalysis/>) was performed to identify the molecular pathways and network based on DA proteins and metabolites. Metabolite names were converted to the Human Metabolome Database (HMDB) ID with MetaboAnalyst 3.0 (<http://www.metaboanalyst.ca>/). The list of protein IDs and HMDB IDs was imported into the online software package IPA to determine their canonical pathways and molecular networks. The IPA content version is 27,821,452 and Release Date at 2016--06-14. Analyses were performed with thresholds of *P* \< 0.05; both direct and indirect relationships were considered.

Verification of protein abundance by western blotting {#Sec24}
-----------------------------------------------------

Sliced muscle tissue of each of two pools of five embryos or chicks at each stage was lysed on ice in RIPA lysis buffer with 1 mM PMSF (phenylmethanesulfonyl fluoride, Beyotime, Shanghai, China) and quantified by the Pierce BCA Protein Assay Kit (Thermo Fisher Scientific, Shanghai, China). Samples containing 32 g of total protein were separated by electrophoresis on 12% (*w*/*v*) SDS-PAGE and transferred to a PVDF membrane (Millipore, Darmstadt, Germany) for 1.5 h at 200 mA. After blocking for 1 h with 5% (w/v) nonfat dry milk in TBST (0.01% (*v*/v) Tween 20 in Tris-buffered saline), the membrane was probed with the primary antibodies, indicated below, diluted in blocking buffer, overnight at 4 °C. After washing with TBST and TBS, the membrane was incubated with HRP-conjugated goat anti-rabbit IgG, (CWBIO, Beijing, China), diluted in blocking buffer at room temperature for 1 h. After thorough washing, immunoreactive proteins were visualized by chemiluminescence with images being captured with an ImageQuant LAS 4000 mini machine (GE, Fairfield, CT), and the signal density data were analyzed with Image-Pro Plus 6.0 software. The primary antibodies, all rabbit polyclonals, were raised against: Long-chain specific acyl-CoA dehydrogenase (ACADL, 1:1000, Sigma-Aldrich), ATP synthase subunit beta (ATP5B, 1:3000, Agrisera, Vännäs, Sweden), alpha 2 Macroglobulin (A2M,1:300, Bioss, Beijing, China), Tropomyosin beta chain (TPM2, 1:400, LifeSpan BioSciences, Seattle, WA), Desmin (DES, 1:300, Abcam, Cambridge, MA), Glyceraldehyde-3-phosphate dehydrogenase (GAPDH, 1:10,000, Abcam), Heat shock protein 70 (Hsp70, 1:2000, Abcam), Pyruvate kinase (PKM2, 1:1000, Thermo Fisher Scientific, Shanghai, China).
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